Pulmonary tuberculosis
MONDO:0006052A bacterial infection that affects the lungs and is caused by Mycobacterium tuberculosis. Most patients with tuberculosis do not have symptoms (latent tuberculosis) and are not contagious. When signs and symptoms occur (active tuberculosis), patients become contagious. The signs and symptoms include chronic cough with blood-tinged sputum, night sweats, fever, fatigue, and weight loss.
Also known as: lung TB, lung tuberculosis, pulmonary TB
132 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Can a vaccine keep TB away for good? new study tests H56:IC31
⭐️ VACCINE ⭐️ CompletedThis study tested an experimental vaccine called H56:IC31 in 831 adults who had just finished treatment for tuberculosis (TB). The goal was to see if the vaccine could lower the chance of TB coming back. Participants were randomly assigned to get either the vaccine or a placebo, …
Phase: PHASE2 • Sponsor: International AIDS Vaccine Initiative • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:07 UTC
-
New TB drug cocktail shows promise in early trial
Disease control CompletedThis study tested an experimental drug called GSK3036656 in combination with other tuberculosis medications in 127 adults with newly diagnosed, drug-sensitive pulmonary TB. Participants received one of several two-drug combinations or standard care for 14 days, then switched to s…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a 4-Month TB cocktail replace the standard 6-Month cure?
Disease control CompletedThis trial tested a new 4-month combination of three drugs (OPC-167832, delamanid, and bedaquiline) against the standard 6-month treatment for drug-susceptible pulmonary tuberculosis. 122 adults with newly diagnosed TB took part. The goal was to see if the shorter regimen is safe…
Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a shorter TB drug combo beat Drug-Resistant TB?
Disease control CompletedThis study tested two different doses of the antibiotic linezolid, combined with three other drugs (bedaquiline, delamanid, and clofazimine), in 138 people with drug-resistant pulmonary tuberculosis. The goal was to see which dose worked better at clearing the infection and was e…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a common diabetes drug help fight TB in HIV patients?
Disease control CompletedThis study looked at whether adding metformin, a diabetes drug, to standard tuberculosis (TB) treatment is safe and tolerable for people also living with HIV. 112 adults with TB and HIV took either standard TB medicines alone or with metformin for 11 weeks. Researchers monitored …
Phase: PHASE2 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a vaccine speed up TB recovery?
Disease control CompletedThis study tested a therapeutic vaccine called RUTI in 41 adults with active pulmonary tuberculosis. Participants received either the vaccine or a placebo alongside their regular antibiotic treatment. The goal was to see if the vaccine could boost the immune system to kill bacter…
Phase: PHASE2 • Sponsor: Archivel Farma S.L. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
TB vaccine booster shows promise in speeding up recovery
Disease control CompletedThis study tested a therapeutic vaccine called RUTI in 140 people with tuberculosis (TB), including drug-resistant forms. Participants received either one dose of RUTI or a placebo alongside their standard TB medications. The goal was to see if the vaccine could help clear the TB…
Phase: PHASE2 • Sponsor: Archivel Farma S.L. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Which antibiotic wins against this tough lung bug?
Disease control CompletedThis study tested two different antibiotics—clarithromycin or moxifloxacin—alongside standard drugs to treat a rare lung infection caused by M. xenopi bacteria. Researchers tracked whether patients' sputum samples became bacteria-free after 6 months. The goal was to find the more…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Rural patients get Hospital-Level care at home in landmark trial
Disease control CompletedThis study looked at whether giving hospital-level care to acutely ill adults in their own homes in rural areas works well. 160 people with various conditions like infections, heart failure, or COPD took part. The goal was to see if this approach could lower costs and help patien…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New combo pill shows promise for HIV patients fighting TB
Disease control CompletedThis study tested a new HIV medication (Biktarvy) taken twice daily in 122 adults who also have drug-sensitive tuberculosis (TB) and are on standard TB treatment. The goal was to see if the new pill can control HIV just as well as the current standard treatment. The study measure…
Phase: PHASE2 • Sponsor: Centre for the AIDS Programme of Research in South Africa • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New TB drug combo shows promise in early trial
Disease control CompletedThis phase IIb trial tested an experimental antibiotic called delpazolid, added to a standard three-drug regimen (bedaquiline, delamanid, moxifloxacin), in 76 adults with newly diagnosed, drug-sensitive pulmonary tuberculosis. The main goals were to check safety and how the drug …
Phase: PHASE2 • Sponsor: LigaChem Biosciences, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:01 UTC
-
TB patients given zinc and selenium show improved immune response
Disease control CompletedThis completed trial tested whether zinc and selenium supplements could boost the immune system of tuberculosis patients. Researchers gave 90 adults with pulmonary TB either fortified cookies or a supplement called Myrin P Fort, and measured changes in body measurements, blood co…
Phase: NA • Sponsor: University of Lahore • Aim: Disease control
Last updated Jun 26, 2026 17:30 UTC
-
New drug cocktail shows promise against Drug-Resistant TB
Disease control CompletedThis study tested a combination of three drugs—bedaquiline, pretomanid, and linezolid—in 109 people with extensively drug-resistant TB (XDR-TB) or multi-drug resistant TB (MDR-TB) that didn't respond to other treatments. Participants took the drugs for 6 to 9 months. The goal was…
Phase: PHASE3 • Sponsor: Global Alliance for TB Drug Development • Aim: Disease control
Last updated Jun 26, 2026 14:29 UTC
-
New rapid test for infection and inflammation put to the test
Diagnosis CompletedThis study looked at how well a new, quick finger-prick test (LumiraDx CRP) measures CRP levels compared to a standard lab test. CRP is a marker of infection, inflammation, or tissue injury. 79 adults with symptoms of these conditions took part. The goal was to see if the new tes…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New rapid test could slash TB diagnosis time in High-Burden regions
Diagnosis CompletedThis study tested a new rapid blood test called SeroSelectTB to see if it can diagnose active tuberculosis (TB) faster than current methods. Over 9,000 adults in South Africa, Tanzania, and Ethiopia who were unwell and suspected of having TB or pneumonia took part. The goal is to…
Phase: NA • Sponsor: Norwegian Institute of Public Health • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Could a simple stool test revolutionize TB diagnosis for kids and HIV patients?
Diagnosis CompletedThis study evaluated a new stool-based test (qPCR) to diagnose tuberculosis (TB) in children under 8 and people living with HIV. Researchers in Mozambique, Eswatini, and Uganda tested nearly 2,000 participants to see if the stool test could improve TB detection rates compared to …
Sponsor: Barcelona Institute for Global Health • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
New scope technique spots hidden TB when standard tests fail
Diagnosis CompletedThis study looked at whether a bronchoscopy (a thin, flexible tube with a camera) can help diagnose tuberculosis in the airways of people whose usual sputum tests came back negative. 63 adults with suspected lung TB took part. The goal was to catch the disease earlier and more ac…
Sponsor: Ain Shams University • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
New PET scan technique aims to sniff out hidden infections
Diagnosis CompletedThis early study tested whether a special PET scan using a radioactive form of vitamin B9 (11C-PABA) can help doctors see infections deep inside the body. Researchers scanned 13 healthy people and patients with known or suspected infections. The goal was to see if this method can…
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Can a chest X-Ray and blood test quickly rule out TB?
Diagnosis CompletedThis study tested two new tools for diagnosing tuberculosis (TB): a software that analyzes chest X-rays (CAD4TB) and a blood test that measures C-reactive protein (CRP). Researchers enrolled 1,400 adults with TB symptoms in Lesotho and South Africa. They compared these tests to s…
Sponsor: Klaus Reither • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Exercise program aims to boost lung health in TB survivors
Symptom relief CompletedThis study tested whether a supervised exercise program can improve heart and lung function and quality of life in people with lasting lung damage from tuberculosis. 60 participants were split into an exercise group and a control group. The goal was to see if physical training he…
Phase: NA • Sponsor: Universidade Federal do Rio de Janeiro • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Could a tiny dose of muscle relaxant make lung scopes safer?
Symptom relief CompletedThis study looked at whether giving a low dose of a muscle relaxant (rocuronium) during bronchoscopy—a procedure where a tube is inserted into the lungs—could reduce complications like throat spasms and coughing. 153 adults having elective bronchoscopy were split into two groups:…
Phase: NA • Sponsor: Harbin Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Probiotic shows promise in easing antibiotic side effects in kids
Symptom relief CompletedThis study tested whether a probiotic called Bifidobacterium breve PRL2020 could reduce stomach issues like diarrhea in 121 children aged 3-12 who were taking amoxicillin antibiotics. The children took the probiotic alongside their antibiotic treatment. The goal was to see if it …
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Study links NSAIDs to severe bacterial infections
Knowledge-focused CompletedThis study looked at 335 adults hospitalized with bacterial infections to see if taking NSAIDs (like ibuprofen) before admission made their infections more severe. Researchers compared those with complicated infections (abscesses, needing surgery) to those with simpler infections…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
VR training matches Real-Life mock homes for nursing skills
Knowledge-focused CompletedThis study tested whether a virtual reality (VR) room called VR CAVE can teach community health nursing skills as effectively as a physical mock home. 150 final-year nursing students practiced home visits for patients with COPD and tuberculosis in both settings. Results showed bo…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Scientists seek perfect antibiotic dose for young burn victims
Knowledge-focused CompletedThis study aimed to find the best dose of the antibiotic ceftazidime for critically ill children with severe burns. Researchers took blood samples from 3 children to measure how the drug moves through the body. The goal was to learn how to personalize dosing to improve treatment …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New antibiotic studied in kids: first step toward better infection treatment
Knowledge-focused CompletedThis early-phase study tested a single dose of the antibiotic omadacycline (Nuzyra) in 23 children aged 8 to 17 who were hospitalized with bacterial infections. Researchers measured how the drug moved through the body and checked for side effects. The goal was to gather safety an…
Phase: PHASE1 • Sponsor: Paratek Pharmaceuticals Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New imaging method could spot hidden bacteria
Knowledge-focused CompletedThis study tested a new imaging technique using a radioactive tracer called 11C-trimethoprim to see how it spreads in the bodies of 16 adults with suspected bacterial infections. Participants had PET/CT scans to track the tracer over time. The goal was to learn how the tracer beh…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
ICU antibiotic dosing: what really matters?
Knowledge-focused CompletedThis study looked at 156 critically ill patients to find out what factors help achieve the right levels of beta-lactam antibiotics in the blood. Researchers collected clinical data and used therapeutic drug monitoring to see which patients reached target concentrations. The goal …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Food as medicine: can nutrition boost TB treatment success?
Knowledge-focused CompletedThis study looked at whether providing nutritional support to people being treated for tuberculosis (TB) improves their outcomes. Researchers compared TB patients in Benin, who receive food baskets and meals, to similar patients in Togo, who do not get systematic nutritional supp…
Sponsor: Boston Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Hidden gut infections may sabotage TB recovery, study suggests
Knowledge-focused CompletedThis completed study looked at 141 people being treated for tuberculosis (TB) to see if intestinal parasites or poor nutrition made their recovery harder. Researchers checked stool samples for parasites and measured weight gain and treatment success. Some participants received nu…
Sponsor: Boston Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Wearable pump trial aims to free hospital patients from IV stands
Knowledge-focused CompletedThis study tested special wearable pumps (elastomeric pumps) to give antibiotics through a drip to hospital patients. Nine adults with bacterial infections took part to see if the pumps are safe, easy to use, and could save time and money compared to traditional methods. The goal…
Phase: NA • Sponsor: Stuart Bond • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
TB drug dosing under the microscope: could this lead to shorter, safer treatment?
Knowledge-focused CompletedThis completed Phase 3 study measured how high doses of the tuberculosis drugs rifapentine and moxifloxacin move through the body in 53 adults with TB. Participants gave multiple blood samples to track drug levels. The goal was to understand the best doses to kill TB bacteria whi…
Phase: PHASE3 • Sponsor: Centers for Disease Control and Prevention • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:56 UTC